AbbVie Inc. against Bayer Aktiengesellschaft — live side-by-side technical comparison.
Prices as of 2026-09-23T20:03:50+00:00 UTC · updates daily
ABBV leads 3 of the 5 windows we measure — over 1 month ABBV is +0.2% and BAYN.DE +1.7%; over year to date ABBV is +16.0% and BAYN.DE +33.2%.
| ABBV | BAYN.DE | |
|---|---|---|
| Price | $265.08 | $49.31 |
| 1 day | -0.1%lead | -0.5% |
| 5 days | +1.0%lead | +0.7% |
| 1 month | +0.2% | +1.7%lead |
| 6 months | +29.4%lead | +28.2% |
| Year to date | +16.0% | +33.2%lead |
| 52-week position | 95% of range | 84% of range |
| 52-week range | $190.75–$269.39 | $25.78–$53.92 |
| vs 50-day average | above $256.43 | above $48.45 |
| vs 200-day average | above $230.16 | above $42.54 |
| RSI (14) | 55 | 50 |
| Next earnings | 2026-10-29 | 2026-11-03 |
ABBV trades at $265.08, above its 50-day average of $256.43, and above the 200-day at $230.16. It sits at 95% of its 52-week range ($190.75–$269.39); 14-day RSI is 55, in neutral territory; an average session moves it about 2.1%. For levels, the first level overhead is $265.97 (0.3% away) and the first support below is $262.28 (1.1% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
BAYN.DE trades at $49.31, above its 50-day average of $48.45, and above the 200-day at $42.54. It sits at 84% of its 52-week range ($25.78–$53.92); 14-day RSI is 50, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $50.00 (1.4% away) and the first support below is $48.45 (1.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
BAYN.DE is the more volatile of the two — an average session moves it 2.5% against 2.1% for ABBV, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: ABBV clearing $265.97 or losing $262.28; BAYN.DE clearing $50.00 or losing $48.45. Until one of them gives way, the relative reading above stands.